3BDO is a butyrolactone derivative that targets FKBP1A and activates the mTOR signaling pathway, inhibiting HUVECs autophagy. 3BDO also inhibited oxLDL-induced apoptosis.

 

Brand: BCM

 

Target: Apoptosis; mTOR; Autophagy

 

Signaling Pathways: Apoptosis; Autophagy; PI3K/Akt/mTOR signaling

 

Solubility: Soluble in DMSO; soluble in Ethanol. Insoluble in Water.

 

GHS: GHS07

Isomeric SMILES: C1C(C(=O)OC1COC2=CC=CC=C2[N+](=O)[O-])CC3=CC=CC=C3  

 

InChIKey: AXPZIVKEZRHGAS-UHFFFAOYSA-N  

 

InChI: InChI=1S/C18H17NO5/c20-18-14(10-13-6-2-1-3-7-13)11-15(24-18)12-23-17-9-5-4-8-16(17)19(21)22/h1-9,14-15H,10-12H2

 

Attribute
[Chem Name]	3-benzyl-5-[(2-nitrophenoxy)methyl]oxolan-2-one
[Synonym]	3BDO
[CAS No.]	890405-51-3
[MDL No.]	MFCD30187363
[Formula]	C18H17NO5
[Molecular]	327.33
[Form]	Colorless to light brown oil
[Storage]	Sealed in dry, 2-8°C

Goods Tag